Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52

NCT04498013 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Mammographic Breast Density

Interventions

DRUG: Cyclodynon
BEHAVIORAL: Lifestyl modification

Sponsor

Dr. Struk Tetiana

Collaborators

[object Object]